Isolated Anti-HBC Positive Subjects and Their Response to Hepatitis B Vaccine

Key Points

• The study finds a variable vaccine response among isolated anti-HBc positive individuals, indicating differing immunity levels.
• Overall, 30% of subjects displayed serological markers for effective immunity post-vaccination, highlighting potential gaps in protection.
• Observational analysis of isolated anti-HBc positive subjects was conducted to assess their response to the hepatitis B vaccine.
• These findings suggest a need for tailored vaccination strategies for this subgroup to ensure optimal immunity.